[HTML][HTML] Therapeutic efficacy and safety of prolonged macrolide, corticosteroid, doxycycline, and levofloxacin against macrolide-unresponsive Mycoplasma …
SG Ha, KJ Oh, KP Ko, YH Sun, E Ryoo… - Journal of Korean …, 2018 - synapse.koreamed.org
Background We aimed to compare the therapeutic efficacy of prolonged macrolide (PMC),
corticosteroids (CST), doxycycline (DXC), and levofloxacin (LFX) against macrolide-
unresponsive Mycoplasma pneumoniae (MP) pneumonia in children and to evaluate the
safety of the secondary treatment agents. Methods We retrospectively analyzed the data of
patients with MP pneumonia hospitalized between January 2015 and April 2017. Macrolide-
unresponsiveness was clinically defined with a persistent fever of≥ 38.0 C at≥ 72 hours …
corticosteroids (CST), doxycycline (DXC), and levofloxacin (LFX) against macrolide-
unresponsive Mycoplasma pneumoniae (MP) pneumonia in children and to evaluate the
safety of the secondary treatment agents. Methods We retrospectively analyzed the data of
patients with MP pneumonia hospitalized between January 2015 and April 2017. Macrolide-
unresponsiveness was clinically defined with a persistent fever of≥ 38.0 C at≥ 72 hours …
Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae …
하석균， 오경진， 고광필， 선용한， 류일… - Journal of Korean …, 2018 - dbpia.co.kr
Background: We aimed to compare the therapeutic efficacy of prolonged macrolide (PMC),
corticosteroids (CST), doxycycline (DXC), and levofloxacin (LFX) against macrolide-
unresponsive Mycoplasma pneumoniae (MP) pneumonia in children and to evaluate the
safety of the secondary treatment agents. Methods: We retrospectively analyzed the data of
patients with MP pneumonia hospitalized between January 2015 and April 2017. Macrolide-
unresponsiveness was clinically defined with a persistent fever of≥ 38.0° C at≥ 72 hours …
corticosteroids (CST), doxycycline (DXC), and levofloxacin (LFX) against macrolide-
unresponsive Mycoplasma pneumoniae (MP) pneumonia in children and to evaluate the
safety of the secondary treatment agents. Methods: We retrospectively analyzed the data of
patients with MP pneumonia hospitalized between January 2015 and April 2017. Macrolide-
unresponsiveness was clinically defined with a persistent fever of≥ 38.0° C at≥ 72 hours …
以上显示的是最相近的搜索结果。 查看全部搜索结果